Clinical Trials Now Enrolling
Sapience is committed to discovering and developing innovative therapies that address a broad range of cancers. Two of our molecules are currently enrolling patients in the clinical trials below.
A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors
Enrolling in the United States and the UK
A Phase 1-2 Study of ST316 in Patients With Advanced Solid Tumors
Enrolling in the United States